• Protein A/G Magnetic Beads: Technical Guide and Best Practic

  2026-06-10

  Protein A/G Magnetic Beads (SKU K1305) streamline antibody purification and protein-protein interaction studies, providing high specificity and minimized background in immunoprecipitation workflows. These recombinant Protein A and Protein G beads are not suitable for diagnostic or therapeutic applications, nor for targets outside IgG Fc regions.

• 7-AAD Cell Viability Assays: Precision Tools for Translation

  2026-06-10

  Explore how advanced 7-amino actinomycin D-based viability assays are transforming cellular analysis in translational immunotherapy. This thought-leadership article bridges mechanistic insights from recent CD38 CAR-T structural studies with strategic assay guidance, spotlighting the APExBIO 7-AAD Cell Viability Assay Kit and its role in multiplexed, high-fidelity research.

• Ferrostatin-1 (Fer-1): Precision Inhibition of Ferroptosis i

  2026-06-09

  Ferrostatin-1 (Fer-1) empowers researchers to precisely dissect and inhibit ferroptosis, supporting advanced workflows in cancer and neurodegeneration studies. This guide translates bench protocols, workflow enhancements, and troubleshooting tips into actionable insights for maximizing the power of Fer-1 in complex oxidative cell death models.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Reporter Advan

  2026-06-09

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) offers robust dual-modality detection for mRNA delivery and transfection studies. This Cap1-capped, 5-moUTP-modified, Cy5-labeled mRNA enables high translation efficiency and reduced innate immune activation in mammalian systems.

• Epigenetic Regulation of Vasoconstriction via TPM3 Khib Modu

  2026-06-08

  This study reveals that HDAC3-driven de-2-hydroxyisobutyrylation of tropomyosin 3 (TPM3) at Lys141 is a pivotal mechanism controlling vascular smooth muscle contractility and abnormal vasoconstriction. By connecting posttranslational modification dynamics to hypertensive vascular dysfunction, the findings highlight new therapeutic avenues and technical considerations for protein-protein interaction analysis in cardiovascular research.

• TEAD Transcription Factors: Prognostic Role and Ferroptosis

  2026-06-08

  This study identifies the TEAD family, especially TEAD2 and TEAD4, as upregulated and prognostically significant in hepatocellular carcinoma (HCC). Integrative bioinformatics and experimental analysis reveal that downregulating TEAD2 promotes ferroptosis in HCC cells, highlighting TEADs as potential diagnostic and therapeutic targets.

• a-MSH, amide: Protocols and Innovation in Pigmentation Resea

  2026-06-07

  a-MSH, amide empowers precision in both pigmentation regulation and anti-inflammatory peptide research, offering reproducible results and workflow versatility. This article details stepwise experimental best practices, troubleshooting strategies, and bridges new protocol insights from recent studies to practical laboratory contexts.

• Mechanisms of Gepotidacin and Implications for DNA Gyrase In

  2026-06-06

  This article analyzes the mechanistic and structural insights gained from the study of gepotidacin’s action on Staphylococcus aureus gyrase. The findings reveal how gepotidacin’s unique mode of inhibiting DNA gyrase differs from fluoroquinolones, providing context for antibiotic resistance research and informing future experimental workflows involving gyrase inhibitors.

• VX-765: Precision Caspase-1 Inhibition for Inflammation Rese

  2026-06-05

  VX-765 offers potent, selective inhibition of caspase-1, empowering researchers to dissect pyroptosis and cytokine release with confidence in both cellular and in vivo models. This guide details optimized workflows, advanced troubleshooting, and actionable protocol parameters to maximize data quality when leveraging VX-765 for inflammation and immune cell death studies.

• FPR2/ALX Stimulation Restricts CNS Autoimmune Astrocytopathy

  2026-06-05

  The reference study demonstrates that stimulating FPR2/ALX with the agonist Quin-C1 modulates microglia and NK cell activity to attenuate neuroinflammation and demyelination in a mouse model of autoimmune astrocytopathy. These findings provide mechanistic insight into the SYK-AKT pathway and highlight a novel immunomodulatory strategy for CNS autoimmune diseases such as NMOSD.

• PF-562271 HCl in Combination Therapies: Redefining FAK/Pyk2

  2026-06-04

  Explore how PF-562271 HCl, a potent FAK/Pyk2 inhibitor, is reshaping cancer research by enabling advanced combination therapies and immune modulation strategies. Discover unique mechanistic insights and protocol guidance that go beyond standard applications.

• CYP2B6 Downregulation by Dominant-Negative ATF5 in Glioblast

  2026-06-04

  This study demonstrates that a cell-penetrating dominant-negative ATF5 peptide can selectively downregulate CYP2B6 expression in glioblastoma cell lines. The findings highlight a new regulatory mechanism for drug-metabolizing enzymes, with potential implications for precision dosing and personalized therapy in oncology.

• AZD-3463: Deep Mechanistic Insights and Translational Impact

  2026-06-03

  Explore the advanced mechanistic landscape of AZD3463, a dual ALK/IGF1R inhibitor, with an in-depth analysis of its pathway selectivity, translational models, and real-world implications for neuroblastoma research. This article uniquely connects molecular mechanisms to practical assay decisions.

• SIX1 Drives De Novo Lipogenesis in Liver Cancer via Transcri

  2026-06-03

  This study elucidates how the transcription factor SIX1 directly upregulates key de novo lipogenesis (DNL) enzymes in liver cancer, promoting tumor growth and metastasis. The findings establish the DGUOK-AS1/microRNA-145-5p/SIX1 regulatory axis as a crucial link between metabolic reprogramming and cancer progression, providing new avenues for therapeutic intervention.

• Technical Guide: PKH26 Red Fluorescent Cell Linker Kit Appli

  2026-06-02

  The PKH26 Red Fluorescent Cell Linker Kit provides a reliable approach for stable, membrane-specific fluorescent labeling, enabling cell tracing and division tracking in vitro and in vivo. It is best used for labeling cell membrane lipid regions and should not be applied to intracellular or non-membrane targets.

14578 records 1/972 page Next 12345 下5页 Last page